CHARLENE BREAUX: Open Payments
NPI 1023728573 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $237
Food & beverage: $125Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $57 |
| Alkermes, Inc. | 1 | $20 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: ABILIFY MAINTENA, ARISTADA, AUSTEDO XR, ZYNLONTA, VRAYLAR.
Industry payments across OR — which companies pay providers there.
